Knowledge about Human Papillomavirus and Time to Complete Vaccination among Vulnerable Female Youth
- PMID: 26846571
- PMCID: PMC4808615
- DOI: 10.1016/j.jpeds.2015.12.070
Knowledge about Human Papillomavirus and Time to Complete Vaccination among Vulnerable Female Youth
Abstract
Objective: To examine the association of knowledge about human papillomavirus (HPV) on the time to completion of the 3-dose quadrivalent vaccine series in an inner-city population of adolescent female subjects at high risk for infection.
Study design: We prospectively followed 139 female subjects aged 14-20 years enrolled in a vaccine surveillance study in New York City during a period of at least 24 months. Participants were given a 30-item true or false survey on HPV at enrollment and ranked according to the number of correct responses. Multivariate Cox regression was used to examine the association between level of knowledge about HPV and time to completion (in days) of vaccine dose 1-3, dose 1-2, and dose 2-3.
Results: Overall time to completion of the 3-dose vaccine ranged from 158 days to 1114 days. Participants in the high knowledge group (top quartile) were significantly more likely to complete the 3-dose series earlier (hazard ratio 1.69, 95% CI 1.03-2.77; P = .04), in particular doses 2-3 (hazard ratio 1.71, 95% CI 1.02-2.89; P = .04), than those with low-to-moderate knowledge (bottom 3 quartiles).
Conclusions: These findings suggest that knowledge of HPV is associated with shorter time to complete the 3-dose HPV vaccine series. Educational campaigns at time of vaccination may be important to improve vaccine adherence.
Copyright © 2016 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Risk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women.J Infect Dis. 2016 Dec 15;214(12):1952-1960. doi: 10.1093/infdis/jiw486. Epub 2016 Oct 12. J Infect Dis. 2016. PMID: 27738056 Free PMC article.
-
Acceptance and compliance with postpartum human papillomavirus vaccination.Obstet Gynecol. 2012 Oct;120(4):771-82. doi: 10.1097/AOG.0b013e31826afb56. Obstet Gynecol. 2012. PMID: 22996094 Clinical Trial.
-
Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?Sex Transm Infect. 2010 Feb;86(1):74-8. doi: 10.1136/sti.2009.037705. Epub 2009 Oct 19. Sex Transm Infect. 2010. PMID: 19841004
-
Human Papillomavirus Infection and Vaccination.J Pediatr Nurs. 2016 Mar-Apr;31(2):e155-66. doi: 10.1016/j.pedn.2015.10.005. Epub 2015 Nov 14. J Pediatr Nurs. 2016. PMID: 26586310 Review.
-
Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population: What Is the Verdict Now?Clin Pediatr (Phila). 2017 Jun;56(7):605-615. doi: 10.1177/0009922817691826. Epub 2017 Feb 20. Clin Pediatr (Phila). 2017. PMID: 28503996 Review.
Cited by
-
Knowledge of preconception care and its association with family planning utilization among women in Ethiopia: meta-analysis.Sci Rep. 2021 May 25;11(1):10909. doi: 10.1038/s41598-021-89819-8. Sci Rep. 2021. PMID: 34035339 Free PMC article.
-
The interaction between pubertal timing and childhood maltreatment on the risk of human papillomavirus infection among adolescent girls and young women.Prev Med. 2020 Sep;138:106126. doi: 10.1016/j.ypmed.2020.106126. Epub 2020 May 8. Prev Med. 2020. PMID: 32389680 Free PMC article.
-
Influence of Gender and Undergraduate Course on the Knowledge about HPV and HPV Vaccine, and Vaccination Rate among Students of a Public University.Rev Bras Ginecol Obstet. 2020 Feb;42(2):96-105. doi: 10.1055/s-0040-1701466. Epub 2020 Mar 30. Rev Bras Ginecol Obstet. 2020. PMID: 32227325 Free PMC article.
-
Young Hungarian Students' Knowledge about HPV and Their Attitude Toward HPV Vaccination.Vaccines (Basel). 2016 Dec 29;5(1):1. doi: 10.3390/vaccines5010001. Vaccines (Basel). 2016. PMID: 28036070 Free PMC article.
-
Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.Vaccine. 2018 Mar 7;36(11):1491-1499. doi: 10.1016/j.vaccine.2017.12.060. Epub 2018 Feb 7. Vaccine. 2018. PMID: 29428177 Free PMC article.
References
-
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. New England Journal of Medicine. 2007;356:1915–1927. - PubMed
-
- Garland S, Hernandez-Avila M, Wheeler C, Perez G, Harper D, Leodolter S, et al. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases. New England Journal of Medicine. 2007;356:1928–1943. - PubMed
-
- Markowitz LE, Dunne EF, Saraiya M, Chesson H, Curtis CR, Gee J, et al. Human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Recommendations. 2014;63:1–23. - PubMed
-
- World Health Organization Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 – conclusions and recommendations. Wkly Epidemiol Rec. 2014;89:221–36. 2015. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources